Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RAMUCIRUMAB vs RASAGILINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RAMUCIRUMAB vs RASAGILINE: Safety Overview

Metric RAMUCIRUMAB RASAGILINE
Total FAERS Reports 5,357 2,731
Deaths Reported 1,444 255
Death Rate 27.0% 9.3%
Hospitalizations 2,066 961
Average Patient Age 63.9 yrs 71.0 yrs
% Female Patients 33.0% 46.2%
FDA Approval Date N/A Apr 9, 2024
Manufacturer Eli Lilly and Company Ascend Laboratories, LLC
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription